G

Glaukos

Medical devices for glaucoma treatment

Senior Engineering Technician

Validation, Compliance & Quality SystemsConfirmed live in the last 24 hours
Full-timeSan Clemente, CA, USA$66.9k - $83.6kIn-person

About the Job

Requirements

  • A high school diploma or GED is required.
  • Six to eight years of experience supporting manufacturing operations in a regulated industry such as medical device, pharmaceutical, or biotechnology is required.
  • At least two years of hands-on experience troubleshooting and supporting manufacturing equipment is required.
  • Experience executing equipment qualifications (IQ/OQ/PQ) and maintaining compliant documentation is required.
  • Working knowledge of cGMP, GDP, and Quality System requirements is required.

Responsibilities

  • Provide technical support to manufacturing operations and ensure equipment readiness.
  • Troubleshoot and resolve equipment- and process-related issues on the production floor.
  • Support calibration, maintenance, and preventive maintenance activities.
  • Execute equipment qualifications (IQ/OQ/PQ) and validation protocols.
  • Maintain accurate documentation and records in compliance with cGMP, GDP, and Quality System requirements.
  • Assist with investigations, nonconformances (NCs), and CAPA activities.
  • Partner cross-functionally with Engineering, Quality, Manufacturing, Supply Chain, and R&D teams.
  • Support operator training on equipment, processes, and procedures.

Desired Qualifications

  • An associate degree, technical certification, or equivalent combination of education and experience is preferred.
  • Cleanroom experience is highly preferred.

About the Company

Glaukos

Medical devices for glaucoma treatment

Glaukos focuses on ophthalmology by developing and commercializing medical devices and therapies for glaucoma, corneal disorders, and retinal diseases. Its products mainly target surgeons who treat eye conditions, with a core technology in micro invasive glaucoma surgery (MIGS). The company’s MIGS devices, such as the Trabecular Micro Bypass Stent and next-generation iStent, are implanted in the eye to improve outflow of eye fluid and lower intraocular pressure, offering a less invasive option compared with traditional surgeries. Glaukos differentiates itself by pioneering MIGS and bringing the first US-approved MIGS device to market in 2012, continuing to expand its portfolio through research, development, and strategic acquisitions. The company aims to improve patient care by providing safer, effective, and longer-lasting treatment options for glaucoma and related eye diseases, addressing unmet needs in ophthalmology.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Aliso Viejo, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Glaukos

See more jobs